Figure 3.

Decreased numbers of functional myeloid dendritic cells (mDCs) in survived acute-on-chronic liver failure (ACLF) patients at baseline. (a, c) Distribution of circulating mDCs and plasmacytoid DCs (pDC) in survived and non-survived ACLF patients. (b, d) Cytokine-releasing capacity of total peripheral blood mononuclear cells (PBMCs) induced by Toll-like receptor ligands in survived and non-survived ACLF patients. Each circle represents an individual. Horizontal bars represent the median values of indicated index. P values are shown. NS, non-survived ACLF patients; S, survived ACLF patients.